KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palvella Therapeutics (PVLA) Tax Rate (2014 - 2018)

Palvella Therapeutics (PVLA) reported Tax Rate of 1.38% for Q4 2018, down 50.0% year-over-year from 2.77% in Q4 2017, and down 96.72% on a QoQ basis from 42.17% in Q2 2018.

Palvella Therapeutics (PVLA) has 4 years of Tax Rate data on file, last reported at 1.38% in Q4 2018.

  • Quarterly Tax Rate fell 50.0% year-over-year to 1.38% in Q4 2018, while the trailing twelve-month figure through Sep 2019 was 0.45% (up 40.0% YoY) and the FY2020 annual result came in at 0.44%, changed N/A from the prior year.
  • Tax Rate eased to 1.38% in Q4 2018 per PVLA's latest filing, from 42.17% in the prior quarter.
  • Across five years, Tax Rate topped out at 42.17% in Q2 2018 and bottomed at 8.78% in Q2 2017.
  • The 4-year median for Tax Rate is 0.0% (2014), against an average of 3.06%.
  • Peak annual rise in Tax Rate reached 5095 bps in 2018, while the deepest fall reached 50 bps in 2018.
  • Tracing PVLA's Tax Rate over 4 years: stood at 0.0% in 2014, then sank by 955566 bps to 5.97% in 2015, then jumped by 132 bps to 1.89% in 2017, then decreased by 27 bps to 1.38% in 2018.
  • Per Business Quant, the three latest PVLA Tax Rate figures stand at 1.38% (Q4 2018), 42.17% (Q2 2018), and 1.89% (Q4 2017).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 57.14
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 5.61
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 17.68
7 Evaxion A 62.56 Bn 62.54 Bn - -6.79
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 12.51
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 7.07
10 Palvella Therapeutics 1.47 Bn 1.21 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2018 1.38
Dec 31, 2018 1.38
Jun 30, 2018 42.17
Jun 30, 2018 42.17
Dec 31, 2017 1.89
Dec 31, 2017 1.89
Sep 30, 2017 -2.11
Sep 30, 2017 -2.11
Jun 30, 2017 -8.78
Jun 30, 2017 -8.78
Dec 31, 2015 -5.97
Dec 31, 2015 -5.97
Sep 30, 2015 -1.04
Sep 30, 2015 -1.04
Jun 30, 2014 0.00
Jun 30, 2014 0.00
Mar 31, 2014 0.00
Mar 31, 2014 0.00